We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Plavix Patent Litigation to Resume, Sanofi Exec Says

Law360 (August 2, 2006, 12:00 AM EDT) -- Patent litigation between Sanofi-Aventis S.A., Bristol-Myers Squibb and Apotex Corp. over a generic version of the blood thinner Plavix will be reinstated, Sanofi Chief Financial Officer Jean-Claude Leroy said on Wednesday.

The comment was made to analysts after the company reported its second quarter results, Dow Jones reported.

Sanofi-Aventis, the distributor of Plavix in Europe, and Bristol-Myers, which sells the drug in the United States, reached a settlement with Apotex Corp. in March in which Apotex agreed to refrain from making generic Plavix in exchange for...
To view the full article, register now.